Method for increasing antibody sequence decoding difficulty by using heavy-labeled amino acid
By using heavy-labeled amino acids in antibody-expressing cells to increase the difficulty of deciphering the antibody sequence, the challenge of intellectual property protection of antibody sequences is solved, the retention of antibody function and market exclusivity is achieved, and the complexity of deciphering is significantly improved.
Patent Information
- Application Number
- CN202410997205.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-24
- Publication Date
- 2024-11-08
AI Technical Summary
The prior art is difficult to effectively protect the intellectual property rights of antibody sequences, and competitors may quickly replicate antibodies, affecting the legitimate rights and interests of the original developer. Traditional methods such as chemical modification or legal protection have limitations and functional effects.
A specific proportion of heavy-labeled amino acids are added to the culture of antibody-expressing cells, and the difficulty of deciphering the antibody sequence is increased by isotope labeling, causing mass spectrometry detection signal to drift, confusing the analysis results, and constructing a sequence barrier to protect intellectual property rights.
Significantly increase the deciphering complexity of antibody sequences, retain the functionality of the antibody, provide effective intellectual property protection and market exclusivity, and reduce the risk of competitors' replication.
Smart Images

Figure BDA0004960569720000051
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biotechnology, and in particular, relates to a method for increasing the difficulty of antibody sequence deciphering by using heavy-labeled amino acids. Background Art
[0002] In the current field of biopharmaceuticals and immunology research, antibodies are an important biological molecule, and the exploration of their specificity and functionality plays an extremely critical role in disease diagnosis, treatment and basic scientific research. Antibodies are composed of two heavy chains and two light chains, of which the variable region (V region) is responsible for recognizing and binding to specific antigens, while the constant region (C region) is involved in effector functions, such as activating immune cells. With the rapid development of gene sequencing technology and proteomics, rapid and accurate analysis of antibody sequences has become possible, which is crucial for the research and development of antibody drugs.
[0003] However, this progress also brings challenges, especially in terms of intellectual property protection and trade secret maintenance. Once the antibody sequence is made public, competitors may quickly copy the antibody, affecting the legitimate rights and interests of the original developer. Therefore, developing effective strategies to increase the difficulty of deciphering antibody sequences and protect the intellectual property rights of antibody sequences has become an urgent problem to be solved.
[0004] Traditional sequence protection methods, such as chemical modification or direct protection under patent law, often have limitations, such as the potential impact on the functionality of the antibody, limited scope of protection, or complex and time-consuming legal procedures. Therefore, there is an urgent need for an innovative technical means that can effectively increase the difficulty of accurate analysis of antibody sequences without changing the original biological activity of the antibody, thereby ensuring the market exclusivity of the antibody product and the interests of the developer. Summary of the invention
[0005] Purpose of the invention: To solve the above technical problems, the present invention provides a method for increasing the difficulty of antibody sequence deciphering by using heavy-labeled amino acids.
[0006] Technical solution: In order to achieve the above-mentioned invention object, the present invention adopts the following technical solution:
[0007] A method for increasing the difficulty of antibody sequence deciphering by using heavy-labeled amino acids, comprising adding a certain proportion of heavy-labeled amino acids to a culture medium for culturing hybridoma cells or recombinant antibody-expressing cells, and finally purifying to obtain a monoclonal antibody with increased difficulty of sequence deciphering.
[0008] As a specific implementation scheme, the heavy-labeled amino acids are 20 common amino acids in proteins. Specifically, the amino acids in the heavy-labeled amino acids are selected from one or more of alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine.
[0009] As a specific embodiment, in the re-labeled amino acids, the re-labeling refers to the isotope labeling of atoms in the amino acid molecules, that is, hydrogen atoms are isotopes. 2 H, carbon atom is an isotope 13 C, nitrogen atoms are isotopes 15 N or oxygen atoms are isotopes 18 O; the type of atoms to be weighted is selected from one or more of hydrogen atoms, carbon atoms, nitrogen atoms and oxygen atoms; the number of atoms to be weighted is from 1 atom to all atoms in the amino acid molecule; the weighting is preferably an isotope labeling of carbon and / or nitrogen in the amino acid molecule.
[0010] As a specific implementation scheme, a certain proportion of heavy-labeled amino acids is added to the culture medium, and the amount added is 10 to 1000% of the required amount of amino acids in the culture medium, that is, on the basis of adding the required light-labeled amino acids, heavy-labeled amino acids with 10 to 1000% of the light-labeled amino acids are added; the preferred amount added is 50 to 200% of the required amount of amino acids in the culture medium.
[0011] As a specific implementation scheme, when culturing hybridoma cells or recombinant antibody-expressing cells, except for adding heavy-labeled amino acids, other culture conditions are not changed, such as culture volume, inoculation amount, culture time, culture stability, carbon dioxide content, etc., and culture is carried out according to normal culture conditions.
[0012] As a specific implementation scheme, the re-labeled monoclonal antibody is directly used as a pure product, which can increase the difficulty of sequence deciphering; or the re-labeled monoclonal antibody is mixed with a non-re-labeled monoclonal antibody, which can also increase the difficulty of sequence deciphering.
[0013] In the method of the present invention, the purified re-labeled antibody cannot be directly matched with the amino acid molecular weight when the amino acid sequence is detected and analyzed by conventional protein spectrum due to the random insertion of re-labeled amino acids, resulting in failure of peptide segment analysis; the re-labeled antibody is only different in isotope, and its physical and chemical properties remain unchanged, which does not affect the antibody performance and can be used directly. If cost issues are considered, it can be mixed with unlabeled antibodies. Preferably, the re-labeled monoclonal antibody is mixed with the un-re-labeled monoclonal antibody, and the proportion of the re-labeled monoclonal antibody is not higher than 50%.
[0014] The method of the present invention is a method for protecting antibody sequences. After the target antibody is expressed under the condition of heavy-labeled amino acids, the physical and chemical properties of the antibody remain unchanged. However, when the protein spectrum is used to parse the sequence, a large number of redundant precursor signals will be obtained. These precursor signals cannot match the corresponding amino acids due to the heavy-labeling, and sufficient precursor signals for correctly parsing the peptide sequence cannot be obtained, thereby achieving the protection of the target antibody sequence.
[0015] Beneficial effects: Compared with the prior art, the present invention proposes an innovative strategy to introduce heavy-labeled amino acids into the antibody to cause the mass spectrometry detection signal to drift, thereby confusing the protein spectrum analysis results and significantly increasing the complexity of accurately deciphering the antibody sequence. This method not only retains the core function of the antibody, but also builds a layer of "sequence barrier", providing a novel and effective solution for the confidentiality of the antibody sequence and the protection of intellectual property rights. DETAILED DESCRIPTION
[0016] The following is a comprehensive description of the scheme of the present invention. The implementation cases described are the most preferred implementation modes of the present invention, but the present invention is not limited to the following examples.
[0017] Example
[0018] In this example, monoclonal antibody A was produced using HEK293 expression cells;
[0019] 1. Culture medium configuration: Use Dulbecco's Modified Eagle Medium (DMEM) culture medium and add 10%
[0020] fetal bovine serum (FBS) and the antibiotic streptomycin;
[0021] 2. Take out the HEK293 cells from liquid nitrogen or freezer, thaw quickly and transfer to pre-warmed culture medium, and activate them at 37°C, 5% CO2 environment, 95% humidity;
[0022] 3. When the cell density reaches about 80%, subculture the cells, digest them with trypsin, and then expand the culture to 1L;
[0023] 4. Transiently transfect the prepared pCDNA3.4 plasmid connected with the nucleic acid sequence of antibody A;
[0024] a. Prepare for transfection when the cell density reaches 70%-80%;
[0025] b. Dissolve 1 mg of plasmid DNA in 10 mL of DMEM medium;
[0026] c. Dissolve 4 mg PEI (polyethyleneimine) in 10 mL DMEM medium;
[0027] d. Mix the plasmid DNA and PEI slowly to avoid foaming and incubate at room temperature for 20 minutes;
[0028] e. adding the mixed reagent to the cell culture system;
[0029] 5. Add 100 mg of the heavy-labeled amino acid L-Lysine 2HCl-[13C6;15N2](K10) of lysine into 1 mL of ddH2O, shake and mix, and filter using a 220 nm filter membrane;
[0030] 6. Add 100 mg of the heavy-labeled amino acid L-Serine-d3 (S3) of serine to 1 mL of ddH2O, shake and mix, and filter using a 220 nm filter membrane;
[0031] 7. Add all of the above two solutions into the HEK293 cell culture system to basically reach the light standard amino acid:
[0032] The amino acid was re-labeled ≈1:1, and transfection expression was continued for 24-48h;
[0033] 8. Harvest the cells and culture medium after expression, and purify and concentrate antibody A;
[0034] a. Separate the supernatant, add the cells to PBS at pH 7.0-7.5, and disrupt the cells by ultrasound;
[0035] b. Centrifuge the supernatant and broken cell solution to remove large particles;
[0036] c. Equilibrate the Protein A / G affinity chromatography column with 3 column volumes of PBS at pH 7.0-7.5;
[0037] d. The culture medium supernatant or cell fragments are adsorbed on the column and flowed through the Protein A / G affinity chromatography column at a uniform speed;
[0038] e. Wash the column with PBS at pH 7.0-7.5 until the absorption at 280 nm is close to the baseline;
[0039] f. Elute the antibody with 0.1M Glycine-HCl pH 2.5-3.0 and immediately neutralize the eluate with 1M Tris-HCl pH 8.0;
[0040] g. Use ultrafiltration centrifuge tubes to concentrate antibodies;
[0041] 9. Take a small amount of antibody A, dilute it in a gradient manner, and use the BCA method to quantify the total amount of protein, and it can be used as a stand-by product;
[0042] Try testing to confirm antibody anti-cracking performance:
[0043] 1. Take 2 portions of 10 μg of antibody A and perform enzyme digestion with trypsin and chymotrypsin respectively. After the digestion is completed, desalt and detect using protein spectrum DDA (Data-Dependent Acquisition) method respectively. Take the following sequence of antibody A (about 1200 amino acids in length) as an example: M S YNGNN K HYAD S VNG R FTI SR ND SK .
[0044] 2. Based on the two enzymes, if we know the target antibody sequence, we will know that the following sequences will be obtained:
[0045] Table 1 Theoretical fragments generated by target peptides after digestion with Trypsin and Chymotrypsin
[0046] Trypsin Chymotrypsin MSYNGNNK MS (too short) HYADSVNGR YNGNNKHYADS FTISR VNGRFTIS NDSK RNDS K (too short)
[0047] 3. For the above 9 cut sequences, excluding the two sequences that are too short, there are still 7 sequences. Since the two amino acids S and K are added with the heavy-labeled amino acids S3 and K10 at a ratio of about 1:1, the actual sequence detected is as follows:
[0048] Table 2 Types of peptides after adding heavy labels
[0049] Trypsin Chymotrypsin MSYNGNNK YNGNNKHYADS MS3YNGNNK YNGNNK10HYADS MSYNGNNK10 YNGNNKHYADS3 MS3YNGNNK10 YNGNNK10HYADS3 HYADSVNGR VNGRFTIS
[0050] HYADS3VNGR VNGRFTIS3 FTISR RNDS FTIS3R RNDS3 NDSK NDS3K NDSK10 NDS3K10
[0051] 4. As shown in the table above, there are only 7 peptide signals before weight labeling, but after weight labeling, the signals become 20. Taking this sequence as an example, the number of signals to be analyzed has increased by about 2 times;
[0052] 5. At the same time, the above is based on the situation where the sequence is known. If the sequence is unknown, the decoding will be based on the molecular weight of the secondary mass spectrometry signal as follows, with YNGNN K HYAD S For example:
[0053] Table 3 YNGNN K HYAD S Peptide and its re-labeled peptide by ion molecular weight (only 1 charge example)
[0054]
[0055] 6. As shown in Table 3, YNGNN K HYAD S The peptide and its three re-labeled peptide forms have different combinations of by ions. When they are analyzed separately, the following results appear:
[0056] a. In the light-labeled SK form, the sequence can be analyzed normally by looking at the difference between by ions;
[0057] b. S3 is re-labeled in S3K form. Since S3 is at the end of the sequence, YNGNN K HYAD can be parsed out, but
[0058] When analyzing the S amino acid, it was found that the molecular weight drifted by 3 Da, which could not be matched and the analysis failed;
[0059] c. K10 re-labeled SK10 form, based on the difference between by ions, YNGNN, HYAD can be analyzed S , but the molecular weight of the middle difference K drifted by 10Da, which could not be matched and the analysis failed;
[0060] d. S3K10 re-labeled S3K10 format, based on the difference between by ions, YNGNN and HYAD can be resolved, but the molecular weight of S drifts by 3Da and the molecular weight of K drifts by 10Da, which cannot match and the resolution fails;
[0061] 7. The above example of a peptide will introduce three types of parsing failures. The entire example sequence is 26 amino acids long. Considering that the entire antibody is about 150kD in size and about 1,200 amino acids in length, its complexity will increase exponentially. When the automated algorithm is unknown and the heavy labeling interference is added, the three parsing failures cannot be resolved, and there will be a large number of redundant signals interfering with the analysis results; if manual analysis is used, the workload will be greatly increased if the spectra are analyzed one by one.
Claims
1. A method to increase the difficulty of antibody sequence deciphering by re-marking amino acids. It is characterized in that The method includes adding a certain proportion of heavy-labeled amino acids to the culture medium for culturing hybridoma cells or recombinant antibody-expressing cells, and finally purifying to obtain heavy-labeled monoclonal antibodies with increased difficulty in sequence deciphering.
2. The method of claim 1 for increasing the difficulty of antibody sequence deciphering by using re-marked amino acids, It is characterized in that The amino acids in the heavy-labeled amino acids are selected from one or more of alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine.
3. The method of increasing the difficulty of antibody sequence deciphering by using re-marked amino acids according to claim 1, It is characterized in that In the case of the re-labeled amino acids, the re-labeling refers to the isotope labeling of the atoms in the amino acid molecules, i.e., the hydrogen atoms are isotopes. 2 H, carbon atom is an isotope 13 C, nitrogen atoms are isotopes 15 N or oxygen atoms are isotopes 18 O; the type of atoms to be weighted is selected from one or more of hydrogen atoms, carbon atoms, nitrogen atoms and oxygen atoms; the number of atoms to be weighted is from 1 atom to all atoms in the amino acid molecule; the weighting is preferably an isotope labeling of carbon and / or nitrogen in the amino acid molecule.
4. The method of claim 1 for increasing the difficulty of antibody sequence deciphering by using re-marked amino acids, It is characterized in that A certain proportion of heavy-labeled amino acids is added to the culture medium, and the amount added is 10 to 1000% of the amount of amino acids required to be added to the culture medium, that is, on the basis of adding the required light-labeled amino acids, 10 to 1000% of the heavy-labeled amino acids are added; the preferred amount added is 50 to 200% of the amount of amino acids required to be added to the culture medium.
5. The method of claim 1 for increasing the difficulty of antibody sequence deciphering by using re-marked amino acids, It is characterized in that When culturing the hybridoma cells or recombinant antibody expressing cells, other culture conditions remain unchanged except for adding the heavy-labeled amino acids.
6. The method of claim 1 for increasing the difficulty of antibody sequence deciphering by using re-marked amino acids, It is characterized in that The heavy-labeled monoclonal antibody is directly used as a pure product, which can increase the difficulty of sequence deciphering; or the heavy-labeled monoclonal antibody is mixed with a non-heavy-labeled monoclonal antibody, which can also increase the difficulty of sequence deciphering.
7. The method of claim 6 for increasing the difficulty of antibody sequence deciphering by using re-marked amino acids, It is characterized in that The re-labeled monoclonal antibody is mixed with the non-re-labeled monoclonal antibody, and the proportion of the re-labeled monoclonal antibody is not higher than 50%.
